Delivery Order SPE2DB22D3501-SPE2DB25FTH89

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S to the Defense Logistics Agency (DLA). The contract, valued at $9,616.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and is set to be completed by February 6, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S to the Defense Logistics Agency (DLA). The $26,138.30 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 14, 2024. The contract has an ultimate completion date of June 17, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLETS 60S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and is a delivery order valued at $4,411.49. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical division. This IDC, valued at up to...
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense-focused agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,454.17 and is a firm fixed-price delivery order with a period of performance through November 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,568.81 and an ultimate completion date of April 16, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the...
This federal contract award is for the delivery of JANUMET 50-1,000 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $8,340.64 and a completion date of July 16, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is for the delivery of JANUMET 50-500 MG TABLET 180S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,107.36 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 24, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,204.89 and is a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of JANUMET 50-500 MG TABLET 180S to the Defense Logistics Agency (DLA), a defense agency. The $1,646.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 16, 2024, with an ultimate completion date of January 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide JANUMET 50-1,000 MG TABLET 180S. The $2,858.95 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTH89
    Delivery Order

This federal contract award is for the delivery of JANUMET 50-1,000 MG TABLET 180S to the Defense Logistics Agency (DLA). The contract, valued at $3,369.93, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 1/29/25, 9:17 AM